Overview
What is Usher Iii Initiative Inc?
Usher III Initiative Inc, based in Chicago, Illinois, is a nonprofit organization dedicated to exploring potential treatments for Usher Syndrome Type 3. Their mission involves identifying therapies, treatments, and ultimately, a cure for this condition. The initiative has pursued a strategic approach, focusing on small molecule chaperone therapy, aiming to slow or potentially reverse the vision loss associated with Usher III. Their primary activity includes conducting research, pre-clinical safety studies, and manufacturing of a lead drug compound for this purpose.
Official website here: www.usheriii.org
Is Usher Iii Initiative Inc legitimate?
Usher Iii Initiative Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Usher Iii Initiative Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.usheriii.org
What is the mission statement of Usher Iii Initiative Inc?
The Usher III Initiative Inc's mission is centered around identifying potential therapies, treatments, and ultimately, a cure for Usher Syndrome Type III. Their primary objective is to develop a treatment that can slow down or potentially reverse the vision loss associated with this condition. To achieve this goal, the initiative has adopted an approach focused on small molecule chaperone therapy. Currently, they are engaged in the continued development of a lead drug compound for Usher Syndrome Type 3, involving research, pre-clinical safety studies, and manufacturing processes.
Official website here: www.usheriii.org
Who is the CEO of Usher Iii Initiative Inc?
What is the revenue of Usher Iii Initiative Inc?
Who are the executives of Usher Iii Initiative Inc and what are their salaries?
- Cynthia Elden (President) [Trustee/Director]
- Mark Ackermann (Director)
- Dr Julia Hayes (Director)
- James C Murray (Director)
- Dr David Saperstein (Director)
- Michael Kraines (Director)
- Dr Paul Sternberg Jr (Director)
- Alicia Derrah (Treasurer, Secretary)
Official website here: www.usheriii.org
Where can I find the form 990 for Usher Iii Initiative Inc?
The Usher Iii Initiative Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.usheriii.org
Learn more at the official website: www.usheriii.org
Mission Statement of Usher Iii Initiative Inc
The Usher III Initiative Inc is committed to identifying potential therapies, treatments, and, ultimately, a cure for Usher Syndrome Type III. Their primary goal is to develop a treatment that can slow down or potentially reverse the vision loss associated with this condition. To achieve this, the initiative has adopted an approach centered on small molecule chaperone therapy. Currently, they are focused on furthering the development of a lead drug compound for Usher Syndrome Type 3, involving rigorous research, pre-clinical safety studies, and manufacturing processes.
Impact
This information is meant to be a general summary of Usher Iii Initiative Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Usher III Initiative Inc is making a significant impact by actively working towards identifying therapies, treatments, and a cure for Usher Syndrome Type III. Their mission to develop a treatment to slow or reverse the vision loss associated with Usher III is crucial for individuals affected by this disease. Through research, pre-clinical safety studies, and manufacturing of lead drug compounds, the organization is dedicated to bringing hope and tangible solutions to those affected by Usher Syndrome Type III. This focused approach on small molecule chaperone therapy underscores their commitment to making a difference in the lives of those battling this disease.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2010
Phone
(312) 896-2509
Principal Officer
Alicia Derrah
Main Address
191 N WACKER DRIVE 1790, CHICAGO, IL, 60606
Website
www.usheriii.org
NTEE Category
Code: G122 - Disease
If you are a representative of Usher Iii Initiative Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.